Research.Patient.info
Cardiomyopathy, Hypertrophic research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
This study is looking into a new medicine called mavacamten for teenagers (12-17 years old) with a heart condition called hypertrophic cardiomyopathy (HCM). It aims to see how well it works, if it's safe, and how the body handles it, to help improve symptoms.
United States · Australia · Canada - active not recruitingPHASE4
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
This study looks at how a new medicine, mavacamten, affects the heart's structure in adults with a specific heart condition called hypertrophic cardiomyopathy. We'll use special MRI scans to see these changes, aiming to better understand the treatment's impact.
United States · Argentina · Australia